This year, the Pharmasyntez Group is Russia's sole representative at one of the world's largest pharmaceutical exhibitions, CPHI&PMEC China, the flagship event in China and the Asia-Pacific region.

The 22nd edition of the exhibition, held on June 19–21 in Shanghai, covers 210,000 square meters and features 3,500 exhibitors from around the world. The event has already attracted a record-breaking 100,000 attendees.

CPHI is an important platform for showcasing cutting-edge technologies and products, as innovation and R&D drive global business expansion and foster international collaboration.

At CPHI&PMEC China, Pharmasyntez hosted over 450 meetings at its booth and signed numerous memoranda of understanding with key global pharmaceutical partners.

The Pharmasyntez Group's participation in CPHI&PMEC China demonstrates its commitment to developing biotech drugs and innovative molecules, as well as the importance of expanding into the global pharmaceutical market.